Arax Advisory Partners’s Sana Biotechnology SANA Stock Holding History

Arax Advisory Partners’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$208K	Buy	59,558 +37,444	+169%	+$121K	﹤0.01%	2227
2026 Q1	$63.7K	Sell	22,114 -36,914	-63%	-$145K	﹤0.01%	1584
2025 Q4	$240K	Sell	59,028 -105,903	-64%	-$474K	0.01%	951
2025 Q3	$586K	Buy	+164,931	New	+$596K	0.01%	846
2024 Q4	–	Sell	-150	Closed	-$624	–	2701
2024 Q3	$624	Hold	150	–	–	﹤0.01%	2370
2024 Q2	$819	Buy	+150	New	+$1.2K	﹤0.01%	2230

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Arax Advisory Partners's SANA Position: Q2 2026 in Review

Arax Advisory Partners increased its Sana Biotechnology (SANA) stake by 169% in Q2 2026, buying an estimated $121K and bringing the position to 59,558 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2227.

Arax Advisory Partners first reported a position in SANA in Q2 2024 and has held it in 6 quarters since. The position peaked at $586K in Q3 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Arax Advisory Partners held 59,558 shares of Sana Biotechnology worth $208K as of Q2 2026.
Arax Advisory Partners bought 37,444 Sana Biotechnology shares in Q2 2026, an estimated $121K.
Sana Biotechnology made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2227 holding.
Arax Advisory Partners first reported a position in Sana Biotechnology in Q2 2024 and has held it in 6 quarters since.
Arax Advisory Partners's Sana Biotechnology position peaked at $586K in Q3 2025.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.